What results are realistic on semaglutide
In the 68-week STEP 1 trial, adults with obesity but not diabetes lost an average of 14.9% of their body weight on the 2.4 mg dose — about 34 pounds — versus 2.4% on placebo. That’s the pivotal number behind every “semaglutide results” claim, and it’s the honest anchor for what to expect.
Read that figure the right way. It’s an average, from a supervised 68-week study where participants got structured diet and activity guidance, regular clinic visits, and clinician support through every dose increase. It is not a promise attached to your body. Some people in STEP 1 lost far more than 15%, some lost far less, and some stopped early. Your own result depends on the dose you reach, your starting point, and what you do alongside the drug.
People with type 2 diabetes generally lose somewhat less — the average in STEP 2 was about 9.6% — a consistent pattern across the GLP-1 class. The full trial breakdown lives on the semaglutide overview.
Semaglutide weight-loss timeline
Weight loss on semaglutide builds slowly, because the dose does. You start at 0.25 mg — a sub-therapeutic “let your gut adjust” dose — and step up roughly every four weeks toward the 2.4 mg weight-management dose. Most of the meaningful loss comes after you reach an effective dose, not in the first weeks.
The table below sketches a realistic arc. Only the 68-week endpoint and placebo figures are from STEP 1 — the month-by-month ranges are illustrative, to show the shape of a typical response, and vary widely from person to person.
| Phase | Dose step | What tends to happen | Illustrative change |
|---|---|---|---|
| Weeks 1–4 | 0.25 mg | Appetite starts to quiet; some water-weight/scale movement; GI side effects cluster here | 0–3% (⚠ verify — illustrative) |
| Weeks 5–8 | 0.5 mg | Smaller portions feel normal; steady, gradual loss begins | 2–5% (⚠ verify — illustrative) |
| Weeks 9–16 | 1.0–1.7 mg | The titration ramp; loss accelerates as the dose climbs | 5–10% (⚠ verify — illustrative) |
| Weeks 17+ | 2.4 mg | Full weight-management dose; loss continues, then gradually slows | building toward the trial average |
| Week 68 | 2.4 mg | STEP 1 endpoint | 14.9% average (~34 lb) |
A few honest caveats. Early scale drops are partly water and gut content, not all fat. Plateaus are normal — the curve flattens as you approach a new set point. And “faster” isn’t better: the ramp is deliberately slow because that’s how you outrun the nausea. If a step-up hits hard, the standard fix is holding the dose longer, not pushing through — see the dosage schedule and side effects.
What semaglutide before-and-after photos actually show (and don’t)
Before-and-after photos are the most-searched thing about this drug and the least reliable. They’re not fake, exactly — but they’re selected, and a photo carries almost no context.
- Selection bias is the whole genre. People post the results that worked. You never see the average outcome, the person who stalled at 6%, or the one who stopped over side effects. A feed of dramatic transformations isn’t a representative sample.
- A photo has no timeframe or dose. The same image could be 6 months or 18, on 1.0 mg or 2.4 mg, with or without a structured diet and training plan. Without those, the picture isn’t evidence of anything you can reproduce.
- A photo can’t separate fat from muscle. Rapid loss on any GLP-1 takes lean mass with it unless resistance training and protein intake are deliberate. Two people down 30 pounds can look and function very differently depending on how much of that was muscle — which is why we cover protecting muscle on a GLP-1 separately.
Why individual results vary
Two people can start semaglutide the same week and end up in very different places. The main drivers:
- The dose you actually reach. Effects track with dose. Someone held at 1.0 mg by side effects or cost won’t match the 2.4 mg trial number — that’s not failure, it’s a different dose.
- Starting weight and BMI. A higher starting weight usually means more absolute pounds lost, even at the same percentage.
- Diet and protein. The drug cuts appetite; it doesn’t choose your food. Adequate protein and a reasonable calorie deficit shape both how much you lose and how much of it is fat.
- Activity — especially resistance training. Movement supports the deficit; lifting protects the muscle you’d otherwise lose.
- Consistency and plateaus. Missed doses, restarts, and stalls all flatten the curve. Plateaus are normal and usually temporary, not a sign the drug stopped working.
Keeping the weight off
The hardest part of the honest picture: semaglutide works while you take it. Its appetite effect ends when the drug does, and the biology that drove your weight up doesn’t disappear.
Withdrawal studies make this concrete. When people stopped semaglutide, they regained a large share of what they’d lost — roughly two-thirds within about a year (⚠ verify) — while those who stayed on it largely kept the loss. That’s why clinicians increasingly frame semaglutide as a long-term or maintenance medication, like a blood-pressure drug, rather than a short course you finish.
None of this is a reason not to start — it’s a reason to treat semaglutide as one tool in a long-term plan that also builds sustainable eating and activity habits.
Estimate your own results
The trial average is a starting point, not a prediction. To translate it into a range for your starting weight and target dose, use the calculator instead of a stranger’s photo.
Semaglutide: the complete guide How it works, the full trial results, dosing, side effects, cost, and how to get itThis page is informational and is not medical advice. Trial figures describe supervised study participants, not expected individual results. Talk to a licensed clinician about whether semaglutide is right for you. See our medical disclaimer.